Aurobindo is starting to build on its pledge to expand operations in New Jersey, literally. The Indian drugmaker this week broke ground on the 567,000-square-foot facility that is slated to include a manufacturing and distribution center and warehouse, according to NJ.com.
The company has said it expects to eventually have 400 to 500 jobs there. The expansions come as Aurobindo is building its business in the U.S. It has said that it has about 45 generic drug applications pending before the FDA.
In addition to the New Jersey project, the drugmaker announced plans in April to spend $31.7 million to turn a former medical facility in Durham, NC, into a manufacturing site. When complete, that project is slated to have 275 workers.
The drugmaker said it decided it would be able to get expanded U.S. production faster by retrofitting a former Teleflex Medical facility near Research Triangle Park, than to build a new manufacturing facility at its New Jersey campus. Aurobindo has been approved for more than $4.6 million in state and local Incentives for the North Carolina project.
